bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427379; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. RIPK1 activates distinct gasdermins in macrophages and neutrophils upon pathogen blockade of innate immune signalling Kaiwen W. Chen1,2,#, Benjamin Demarco1, Rosalie Heilig1, Saray P Ramos1, James P Grayczyk3, Charles-Antoine Assenmacher3, Enrico Radaelli3, Leonel D. Joannas4,5, Jorge Henao-Mejia4,5,6, Igor E Brodsky3,5, Petr Broz1# 1Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland 2Immunology Programme and Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 3Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA 4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 5Institue for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA 6Division of Protective Immunity, Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA. #Correspondence to:
[email protected] or
[email protected] Keywords: gasdermin, RIPK1, Yersinia, caspase-8, IL-1 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427379; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.